These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 963908)

  • 1. Surface receptors on human haematopoietic cell lines.
    Huber C; Sundström C; Nilsson K; Wigzell H
    Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse red cell receptors on human hematopoietic cell lines.
    Sundström C; Sällström J; Nilsson K
    J Clin Lab Immunol; 1980 Mar; 3(2):99-103. PubMed ID: 7205935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers on lymphocytes of multiple sclerosis patients.
    Nowak J; Wajgt A
    Clin Exp Immunol; 1975 Aug; 21(2):278-83. PubMed ID: 1102165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    Theofilopoulos AN; Dixon FJ; Bokisch VA
    J Exp Med; 1974 Oct; 140(4):877-94. PubMed ID: 4139225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface immunoglobulin in immunoproliferative diseases.
    Teodorescu M; Mayer EP
    Ann Clin Lab Sci; 1978; 8(5):353-65. PubMed ID: 101125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent movement of surface immunoglobulin from Fc receptors on lymphocyte membranes.
    Ramasamy R; Lawson Y
    Immunology; 1975 Feb; 28(2):301-4. PubMed ID: 1123249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
    Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
    J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological analysis of human lymphocytes bearing different surface receptors].
    Sidorenko SP; Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Tsitologiia; 1979 Feb; 21(2):186-90. PubMed ID: 311965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte receptors. I. Receptors for Fc of IgG and complement (C3b) on immunoglobulin-bearing, antigen-binding and antibody-secreting cells.
    McConnell I; Hurd CM
    Immunology; 1976 Jun; 30(6):825-33. PubMed ID: 800392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subpopulations of human lymphoblastoid cell lines. Correlation with the expression of surface receptors and content of Epstein-Barr virus genome.
    Yount WJ; Utsinger PD; Hutt LM; Buchanan PD; Korn JH; Fuller CR; Logue M; Pagano JS
    Scand J Immunol; 1976; 5(6-7):795-810. PubMed ID: 62390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Aug; 25(2):319-27. PubMed ID: 1085238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizaiton of two populations of human lymphocytes bearing easily detectable surface immunoglobulin.
    Horwitz DA; Lobo PI
    J Clin Invest; 1975 Dec; 56(6):1464-72. PubMed ID: 53240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human peripheral lymphocytes bearing surface immunoglobulin do not have readily detectable Fc receptors.
    Alexander EL; Henkart PA
    Clin Exp Immunol; 1978 Aug; 33(2):332-9. PubMed ID: 363317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human lymphocyte surface markers after allogeneic activation: increase of Fc receptors-bearing cells.
    Meroni PL; Ciboddo GF; Colombo G; Rugarli C
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):52-6. PubMed ID: 552836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.